WeedMD Inc (CVE:WMD) (OTCQX:WDDMF) is bringing sales of its medical cannabis products under one marketplace, which will reduce costs and re-direct funds to develop new offerings and patient services, the company told investors.
The cannabis producer and distributor will complete its full patient migration to its Starseed Medicinal online marketplace by early October this year and expand its offerings alongside, it said.
READ: WeedMD wins Health Canada approval to produce and distribute all cannabis formats from its flagship site in Strathroy, Ontario
"Uniting our medical channel under one marketplace provides our patients with a promise of unparalleled access to more strains, a diverse selection of product formats including vapes and soon, Mary’s topical gels and creams,” said Moe Jiwan, chief customer officer at WeedMD.
"It also includes ease of access to our patient services with same-day shipping and delivery, access to a robust network of healthcare professionals, a client care team available seven days a week and direct billing to insurance providers.
"Moving forward, we will continue to open product channels to our medical patients first as we introduce strain-specific formats derived from some of our most popular genetics at an optimum price point," Jiwan added.
The Starseed Medicinal marketplace and its 'one-of-a-kind' proprietary technology takes online orders and intuitively completes direct billing adjudication and processing, highlighted WeedMD.
Additionally, the products on its Starseed marketplace carry Product Identification Numbers (PINs) allowing health-care practitioners, pharmacists, patients and insurers a greater understanding of how medical cannabis can be used.
The simplified sales platform will provide WeedMD's patients with full access to its produced dried flower, oil concentrates, softgel capsules and Aurum vaporization (vape) products and services such as same-day delivery.
WeedMD owns and operates a 158 acre state-of-the-art greenhouse, outdoor and processing facility in Ontario as well as a fully-licensed 26,000 sq ft processing facility, specializing in cannabis extraction in the Canadian province.
With the addition of Starseed, a medical-centric operator based in Bowmanville, Ontario, WeedMD has expanded its multi-channeled distribution strategy.
Shares eased 3.2% on the day to stand at C$0.30 each.
Contact the author at giles@proactiveinvestors.com